Cytek Biosciences Inc (CTKB) — Cash Flow Quality Index
Cytek Biosciences Inc (CTKB) has a Cash Flow Quality Index of 0.21x as of December 2024. Operating cash flow of $2.00 Million is below net income of $9.64 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore CTKB total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cytek Biosciences Inc Cash Flow Quality Index (2020–2022)
Historical Cash Flow Quality Index for Cytek Biosciences Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Cytek Biosciences Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Cytek Biosciences Inc (2020–2022)
Year-by-year earnings quality comparison for Cytek Biosciences Inc. For live market cap and the full company financial profile, see Cytek Biosciences Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -4.92x | $-12.23 Million | $2.48 Million | ▼ -421.9% |
| 2021 | 1.53x | $4.63 Million | $3.03 Million | ▲ +95.9% |
| 2020 | 0.78x | $15.16 Million | $19.41 Million | — |